Clinical Trials and Interventions Governance

HRB Strategy 2016-2020: Research. Evidence. Action supports the design, conduct and delivery of healthcare intervention studies in order to improve health outcomes and health service delivery.

Clinical trials and interventions are an essential step in translating research discoveries and knowledge into new ways of treating patients, delivering care or changing behaviour.

The HRB is committed to ensuring that its funded research adheres to good research governance which ensures:

  • The safeguarding of participants in health research
  • The enhancement of the ethical and scientific quality of research
  • The mitigation of risk and
  • The avoidance of research waste

To ensure good research governance is adhered to the HRB has developed a Clinical Trial and Interventions Policy which sets out the HRB requirements for Host Institutions before, during and after the conduct of clinical trials.

The policy covers clinical trials and interventions where the HRB is directly funding the trials through the following HRB schemes:

  • Definitive Interventions and Feasibility Awards (DIFA) and
  • Clinical Trial Networks (CTNs)


HRB Policy on Clinical Trials and Interventions Governance